Zegfrovy Tablet, Film Coated
Product Images NDC 84694-102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zegfrovy (NDC 84694-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dizal Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Splzegfrovy 01)

Chemical structure diagram of the active ingredient Sunvozertinib. The structure shows various rings, functional groups, and elements including nitrogen, oxygen, fluorine, and chlorine atoms arranged to represent the molecule's framework.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Carton)

Packaging label for ZEGFROVY 150 mg film-coated tablets containing sunvozertinib. The label displays the product name, strength, and active ingredient prominently, along with the quantity of 30 tablets per package. It includes the NDC number 84694-101-01, manufacturer Dizal Pharmaceutical Co., Ltd., and distributor AstraZeneca Pharmaceuticals LP. Storage instructions and caution to keep out of reach of children are also visible.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Carton)

Packaging label for ZEGFROVY (sunvozertinib) 200 mg film-coated tablets, oral use. The carton indicates 30 tablets per package, marked Rx only, with a barcode and manufacturer details for Dizal Pharmaceutical Co., Ltd. The label includes storage instructions and trademarks related to AstraZeneca.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.